Vitamin E treatment in tardive dystonia

Clinical Neuropharmacology

Volumn 20, Issue 5, 1997, Pages 434-437

  Dannon, Pinhas N ^a   Grunhaus, Leon ^a   Iancu, Iulian ^a   Braf, Alon ^a   Lepkifker, Elic ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Abnormal involuntary movement scale (AIMS); Tardive dystonia; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CARBAMAZEPINE; CLOTIAPINE; HALOPERIDOL; LEVOMEPROMAZINE; LITHIUM CARBONATE; NEUROLEPTIC AGENT;

ABDOMINAL CRAMP; ADULT; AGGRESSION; ARTICLE; CASE REPORT; DEPRESSION; DOPAMINE METABOLISM; DOSE RESPONSE; HEADACHE; HUMAN; MALE; MANIA; MOTOR DYSFUNCTION; NAUSEA; PRIORITY JOURNAL; PSYCHOSIS; RASH; SCHIZOIDISM; TARDIVE DYSKINESIA; VOMITING;

EID: 0030846227     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199710000-00007     Document Type: Article

References (20)

1. Rosse RB, Allen A, Lux W. Baclofen treatment in a patient with tardive dystonia. J Clin Psychiatry 1986;47:474-5.
2. Wojcik JN, Falk WE, Gelenberg AJ. A review of 32 cases of tardive dystonia. Am J Psychiatry 1991;148:1055-9.
3. Yazici O, Kandemir Y, Ozguroglu M. Spontaneous improvement of tardive dystonia during mania. Br J Psychiatry 1991;158:847-50.
4. Burke RE. Tardive dyskinesia: current clinical issues. Neurology 1982;34:1348-53.
5. Yadalam KG, Korn ML, Simpson GM. Tardive dystonia: four case histories. J Clin Psychiatry 1990;51:17-20.
6. Quinn NP, Lang AE, Marsden CD. Lisuride in dystonia. Neurology 1985;35:766-9.
7. Egan MF, Hyde TM, Albers GW, et al. Treatment of tardive dyskinesia with vitamin E. Am J Psychiatry 1992;149:773-7.
8. Stahl S, Berger PA. Bromocriptine, physotigmine, and neurotransmitter mechanisms in the dystonias. Neurology 1982;32:889-92.
9. Elkashef AM, Ruskin PE, Bacher N, Barrett D. Vitamin E in the treatment of tardive dyskinesia. Am J Psychiatry 1990;147:505-6.
10. Lohr JB, Cadet J, Lohr MA, et al. Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms. Schizophr Bull 1988;14:291-6
11. Halliwell B. Oxidant and the central nervous system: some fundamental question. Acta Neurol Scand 1989;126:23-33.
12. Fahn S. High dosage anticholinergic therapy in dystonia. Neurology 1983;33:1255-61.
13. Lohr JB, Zuczenski R, Bracha S. Increased indices of free radical activity in the CSF of patients with tardive dyskinesia. Biol Psychiatry 1990;28:535-9.
14. Shriqui CL, Bradwejn J, Annable L, Jones BD. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo controlled study. Am J Psychiatry 1992;149:391-3.
15. Adler LD, Peselow E, Rotrosen J, et al Vitamin E treatment in tardive dyskinesia. Am J Psychiatry 1993;150:9:1405-7.
16. Dabiri LM, Pasta D, Darby JK, et al. Effectiveness of vitamin E for treatment of long-term tardive dyskinesia. Am J Psychiatry 1994;151:925-6.
17. Lohr JB, Cadet J, Lohr MA, Jeste DV, Wyatt RJ. Alpha-tocopherol in tardive dyskinesia [Letter]. Lancet 1987;i:913-4.
18. Dannon PN, Lepkifker E, Iancu I, Ziv R, Horesh N, Kotler M. Vitamin E treatment in tardive dyskinesia. Hum Psychopharmacol 1997.
19. American Pschiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (DSMIV). Washington, DC: American Psychiatric Association, 1994.
20. Guy W, ed. ECDEU. Washington, DC: U.S. Department of Health. 1976:534-7.